MARWELL BIO INC.

Biotech · Private

AI-based computational platform for designing novel therapeutic antibody drug candidates

marwell.bio →
Grants
$295K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
7
0 granted · 7 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I:Advanced Deep Learning Technologies for Designing Humanized Antibody$294,822
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3139SEAK Therapeutics, LLC——
3140ALCAMENA STEM CELL THERAPEUTICS, LLC——
3141FIBROTHERAPEUTICS INC——
3142MARWELL BIO INC.——
3143Iria Pharma, LLC——
3144DINYA DNA INC—$3.8M
3145CARDIAC RSK3 INHIBITORS, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 7
  • Machine Learning For Designing Antibodies And Nanobodies In-silicoapplication
  • Machine Learning For Designing Antibodies And Nanobodies In-silicoapplication
  • Machine Learning For Designing Antibodies And Nanobodies In-silicoapplication
  • Machine Learning For Designing Antibodies And Nanobodies In-silicoapplication
  • Machine Learning For Designing Antibodies And Nanobodies In-silicoapplication
  • Machine Learning For Designing Antibodies And Nanobodies In-silicoapplication
  • Machine Learning For Designing Antibodies And Nanobodies In-silicoapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.